Investig Clin Urol.  2019 Jul;60(4):331-332. 10.4111/icu.2019.60.4.331.

Letter to the editor: Prognostic significance of preoperative and follow-up neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with non-metastatic clear cell renal cell carcinoma

• Joob B
• Wiwaniitkit V

• KMID: 2450552
• DOI: http://doi.org/10.4111/icu.2019.60.4.331

Abstract

No abstract available.

MeSH Terms

Carcinoma, Renal Cell*
Follow-Up Studies*
Humans

Reference

1. Kim TW, Lee JH, Shim KH, Choo SH, Choi JB, Ahn HS, et al. Prognostic significance of preoperative and follow-up neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with non-metastatic clear cell renal cell carcinoma. Investig Clin Urol. 2019; 60:14–20.

2. Wiwanitkit V. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and heart failure. Arq Bras Cardiol. 2016; 106:265.

3. Wiwanitkit V. Neutrophil to lymphocyte ratio in allergic rhinitis. Eur Arch Otorhinolaryngol. 2016; 273:3443.

4. Bruegel M, Nagel D, Funk M, Fuhrmann P, Zander J, Teupser D. Comparison of five automated hematology analyzers in a university hospital setting: Abbott Cell-Dyn Sapphire, Beckman Coulter DxH 800, Siemens Advia 2120i, Sysmex XE-5000, and Sysmex XN-2000. Clin Chem Lab Med. 2015; 53:1057–1071.

5. Park Y, Song J, Song S, Song KS, Ahn MS, Yang MS, et al. Evaluation of the Abbott Cell-Dyn Sapphire hematology analyzer. Korean J Lab Med. 2007; 27:162–168.